Literature DB >> 31879129

Shank3 Binds to and Stabilizes the Active Form of Rap1 and HRas GTPases via Its NTD-ANK Tandem with Distinct Mechanisms.

Qixu Cai1, Tomohisa Hosokawa2, Menglong Zeng1, Yasunori Hayashi2, Mingjie Zhang3.   

Abstract

Shank1/2/3, major scaffold proteins in excitatory synapses, are frequently mutated in patients with psychiatric disorders. Although the Shank N-terminal domain and ankyrin repeats domain tandem (NTD-ANK) is known to bind to Ras and Rap1, the molecular mechanism underlying and functional significance of the bindings in synapses are unknown. Here, we demonstrate that Shank3 NTD-ANK specifically binds to the guanosine triphosphate (GTP)-bound form of HRas and Rap1. In addition to the canonical site mediated by the Ras-association domain and common to both GTPases, Shank3 contains an unconventional Rap1 binding site formed by NTD and ANK together. Binding of Shank3 to the GTP-loaded Rap1 slows down its GTP hydrolysis by SynGAP. We further show that the interactions between Shank3 and HRas/Rap1 at excitatory synapses are promoted by synaptic activation. Thus, Shank3 may be able to modulate signaling of the Ras family proteins via directly binding to and stabilizing the GTP-bound form of the enzymes.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HRas; Rap1; Ras GTPase; Shank3; SynGAP; synaptic scaffold proteins

Mesh:

Substances:

Year:  2019        PMID: 31879129     DOI: 10.1016/j.str.2019.11.018

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  8 in total

1.  Autism-associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses.

Authors:  Michael Bucher; Stephan Niebling; Yuhao Han; Dmitry Molodenskiy; Fatemeh Hassani Nia; Hans-Jürgen Kreienkamp; Dmitri Svergun; Eunjoon Kim; Alla S Kostyukova; Michael R Kreutz; Marina Mikhaylova
Journal:  Elife       Date:  2021-05-04       Impact factor: 8.140

Review 2.  A perspective on molecular signalling dysfunction, its clinical relevance and therapeutics in autism spectrum disorder.

Authors:  Sushmitha S Purushotham; Neeharika M N Reddy; Michelle Ninochka D'Souza; Nilpawan Roy Choudhury; Anusa Ganguly; Niharika Gopalakrishna; Ravi Muddashetty; James P Clement
Journal:  Exp Brain Res       Date:  2022-09-05       Impact factor: 2.064

Review 3.  SHANK family on stem cell fate and development.

Authors:  Xu Liu; Mengmeng Yuan; Benson Wui-Man Lau; Yue Li
Journal:  Cell Death Dis       Date:  2022-10-18       Impact factor: 9.685

4.  CaMKIIα-driven, phosphatase-checked postsynaptic plasticity via phase separation.

Authors:  Qixu Cai; Menglong Zeng; Xiandeng Wu; Haowei Wu; Yumeng Zhan; Ruijun Tian; Mingjie Zhang
Journal:  Cell Res       Date:  2020-11-24       Impact factor: 25.617

5.  A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners.

Authors:  Soheila Rezaei Adariani; Neda S Kazemein Jasemi; Farhad Bazgir; Christoph Wittich; Ehsan Amin; Claus A M Seidel; Radovan Dvorsky; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2021-04-27       Impact factor: 5.157

6.  The Neomycin Resistance Cassette in the Targeted Allele of Shank3B Knock-Out Mice Has Potential Off-Target Effects to Produce an Unusual Shank3 Isoform.

Authors:  Chunmei Jin; Hyojin Kang; Taesun Yoo; Jae Ryun Ryu; Ye-Eun Yoo; Ruiying Ma; Yinhua Zhang; Hyae Rim Kang; Yoonhee Kim; Hyunyoung Seong; Geul Bang; Sangwoo Park; Seok-Kyu Kwon; Woong Sun; Hyunkyung Kim; Jin Young Kim; Eunjoon Kim; Kihoon Han
Journal:  Front Mol Neurosci       Date:  2021-01-11       Impact factor: 5.639

7.  Case Report: Lennox-Gastaut Epileptic Encephalopathy Responsive to Cannabidiol Treatment Associated With a Novel de novo Mosaic SHANK1 Variant.

Authors:  Justyna Paprocka; Szymon Ziętkiewicz; Joanna Kosińska; Ewa Kaczorowska; Rafał Płoski
Journal:  Front Genet       Date:  2021-11-29       Impact factor: 4.599

8.  Mutations affecting the N-terminal domains of SHANK3 point to different pathomechanisms in neurodevelopmental disorders.

Authors:  Daniel Woike; Emily Wang; Debora Tibbe; Fatemeh Hassani Nia; Antonio Virgilio Failla; Maria Kibæk; Tinett Martesen Overgård; Martin J Larsen; Christina R Fagerberg; Igor Barsukov; Hans-Jürgen Kreienkamp
Journal:  Sci Rep       Date:  2022-01-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.